A Fortune 500 Life Sciences Enterprise Chooses Arkivum to Provide Long Term Management of Its GxP Regulated Research Data
A Fortune 500 Life Sciences enterprise chooses Arkivum to provide long term management of its regulated research data generated by its FDA Class III medical devices.
- A Fortune 500 Life Sciences enterprise chooses Arkivum to provide long term management of its regulated research data generated by its FDA Class III medical devices.
- Arkivum will provide a long-term data management service and solution for the organisation to manage its GxP regulated research data in a compliant and scalable manner, ensuring digital data preservation, future access and usability of its data for years to come.
- Arkivum will play a pivotal role as the enterprise is transforming their data strategy and data management workflows to remove silos generated as a result of acquisitions to build a sustainable, centralised long-term data management strategy.
- George Waidell, VP of Life Sciences at Arkivum adds, Arkivum will provide our customer with complete confidence their research data will be accessible and usable for as long as they need it.